Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonic Neoplasms | 2 | 2025 | 272 | 1.400 |
Why?
|
| Acrolein | 2 | 2023 | 11 | 0.990 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 105 | 0.920 |
Why?
|
| Glioblastoma | 3 | 2023 | 375 | 0.900 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 652 | 0.490 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2025 | 39 | 0.430 |
Why?
|
| Reactive Oxygen Species | 2 | 2025 | 538 | 0.340 |
Why?
|
| Brain Neoplasms | 4 | 2023 | 1411 | 0.320 |
Why?
|
| Glioma | 2 | 2023 | 540 | 0.290 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2025 | 27 | 0.240 |
Why?
|
| HCT116 Cells | 1 | 2025 | 63 | 0.240 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2025 | 40 | 0.240 |
Why?
|
| Symporters | 1 | 2025 | 78 | 0.230 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 131 | 0.230 |
Why?
|
| Glycolysis | 1 | 2025 | 173 | 0.230 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 701 | 0.220 |
Why?
|
| Adaptation, Physiological | 1 | 2025 | 289 | 0.210 |
Why?
|
| Terphenyl Compounds | 1 | 2022 | 2 | 0.200 |
Why?
|
| Macrocyclic Compounds | 1 | 2022 | 12 | 0.200 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 296 | 0.190 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2022 | 80 | 0.190 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2022 | 36 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 132 | 0.180 |
Why?
|
| Neutrophils | 1 | 2023 | 403 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 318 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 512 | 0.170 |
Why?
|
| Substantia Nigra | 1 | 2020 | 37 | 0.160 |
Why?
|
| Spermidine | 1 | 2019 | 5 | 0.160 |
Why?
|
| Single-Chain Antibodies | 1 | 2020 | 45 | 0.160 |
Why?
|
| Corpus Striatum | 1 | 2020 | 97 | 0.160 |
Why?
|
| Acetyltransferases | 1 | 2019 | 92 | 0.160 |
Why?
|
| Antioxidants | 1 | 2022 | 382 | 0.160 |
Why?
|
| alpha-Synuclein | 1 | 2020 | 134 | 0.150 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3805 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 2141 | 0.130 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2016 | 8 | 0.130 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 63 | 0.130 |
Why?
|
| Dinoprostone | 1 | 2016 | 83 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2016 | 84 | 0.120 |
Why?
|
| Extracellular Vesicles | 1 | 2016 | 59 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2019 | 4948 | 0.120 |
Why?
|
| Humans | 10 | 2025 | 134451 | 0.100 |
Why?
|
| Parkinson Disease | 1 | 2020 | 740 | 0.100 |
Why?
|
| Blood-Brain Barrier | 2 | 2023 | 159 | 0.090 |
Why?
|
| Stem Cells | 1 | 2016 | 754 | 0.090 |
Why?
|
| Stroke | 1 | 2019 | 1079 | 0.090 |
Why?
|
| Mutation | 1 | 2023 | 6343 | 0.080 |
Why?
|
| Rats | 3 | 2021 | 3892 | 0.080 |
Why?
|
| Chemoradiotherapy | 1 | 2023 | 127 | 0.050 |
Why?
|
| Speech | 1 | 2023 | 78 | 0.050 |
Why?
|
| Animals | 5 | 2023 | 36599 | 0.050 |
Why?
|
| Language | 1 | 2023 | 222 | 0.040 |
Why?
|
| Microbubbles | 1 | 2021 | 12 | 0.040 |
Why?
|
| Neuronavigation | 1 | 2021 | 10 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2023 | 405 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 316 | 0.040 |
Why?
|
| Immunization | 1 | 2021 | 315 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 232 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1493 | 0.040 |
Why?
|
| Dependovirus | 1 | 2020 | 152 | 0.040 |
Why?
|
| Glutathione | 1 | 2019 | 201 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 652 | 0.040 |
Why?
|
| Brain | 2 | 2021 | 3227 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2020 | 365 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 720 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 826 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1320 | 0.030 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2016 | 13 | 0.030 |
Why?
|
| Caveolae | 1 | 2016 | 9 | 0.030 |
Why?
|
| Cell Shape | 1 | 2016 | 70 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 63 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 52 | 0.030 |
Why?
|
| Integrins | 1 | 2016 | 103 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 143 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 362 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 5227 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3196 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 21831 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 920 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 498 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6626 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2016 | 938 | 0.020 |
Why?
|
| Middle Aged | 2 | 2023 | 29482 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2866 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3869 | 0.020 |
Why?
|
| Female | 3 | 2023 | 72121 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4816 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4889 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 3445 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 19084 | 0.020 |
Why?
|
| Male | 2 | 2023 | 66293 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 32033 | 0.010 |
Why?
|